Analog Devices stock slips into year-end as chip shares cool; Fed minutes and ADI earnings on deck

Analog Devices stock slips into year-end as chip shares cool; Fed minutes and ADI earnings on deck

NEW YORK, December 29, 2025, 10:34 PM ET — Market closed

Analog Devices Inc shares fell 0.44% to close at $275.63 on Monday, tracking a softer session for semiconductors and the broader U.S. market. Texas Instruments dropped 0.67% and NXP Semiconductors slid 1.08%, while the S&P 500 ended down 0.35%. 1

The late-December drift matters because thin, year-end trading can magnify price moves even when company news is scarce. “In light volume trading, we’re seeing a reversal of what we saw over the last couple of days,” said Rob Haworth, senior investment strategist at U.S. Bank Wealth Management. 2

For rate-sensitive growth stocks such as semiconductors, the next macro signal is the Federal Reserve’s December minutes, after policymakers cut rates earlier this month but warned they could stay on hold in the near term. Traders are pricing in two more cuts for 2026, Reuters reported.

The Philadelphia Semiconductor Index closed at 7,178.27, down 31.94 points, according to Nasdaq index data. 3

Analog Devices has now posted two straight declines, after ending at $276.84 on Dec. 26. Shares remain below the $284.23 intraday high hit on Dec. 12, with recent support forming near $270 after the Dec. 17 low of $270.14, according to StockAnalysis data.

Analog Devices designs analog and mixed-signal chips, components that convert and condition real-world signals — such as temperature, sound and motion — for use in electronic systems. The company sells into industrial and communications equipment, with automotive another key end market, according to Reuters company information. 4

The most recent company catalyst remains its late-November results, when Analog Devices reported stronger-than-expected quarterly performance and guided above analyst expectations for fiscal first-quarter revenue and adjusted profit. The company projected revenue of about $3.1 billion, plus or minus $100 million, and adjusted profit of about $2.29 per share, plus or minus 10 cents, while analysts had been looking for about $2.96 billion in revenue and $2.16 per share, Reuters reported at the time. 5

The guidance keeps attention on whether the analog chip downturn is easing after a period of weaker demand signals across parts of the sector. In October, Texas Instruments warned the market could stay soft longer than expected, a read-through that investors have used to frame expectations for analog peers such as Analog Devices. 6

For Analog Devices, traders have been watching order momentum in industrial and communications, and whether customers keep working down inventories without forcing price concessions. Gross margin and free cash flow trends are also in focus as the company moves through fiscal 2026.

Before the next session, attention turns to the Fed minutes from the Dec. 9-10 meeting, scheduled for release at 2:00 p.m. ET Tuesday, according to the central bank’s calendar.

Earlier Tuesday, investors will also get U.S. house price readings — including the S&P/Case-Shiller index — and the Chicago PMI, data points that can move rate expectations in thin markets. 7

On the company calendar, Analog Devices has not confirmed its next earnings publication date, but MarketBeat’s earnings tracker estimates the report is due on Wednesday, Feb. 18, 2026, based on prior reporting patterns. 8

U.S. markets will be closed Thursday for New Year’s Day, setting up another holiday-shortened stretch that often comes with lighter volumes and sharper sector swings. 9

Stock Market Today

GSK share price set for Monday watch after EU clears Nucala COPD use

GSK share price set for Monday watch after EU clears Nucala COPD use

7 February 2026
GSK shares closed Friday up 0.83% at a 52-week high after the EU approved Nucala for certain uncontrolled COPD patients. Insider filings showed chairman Jonathan Symonds bought 2,500 shares while executive David Redfern sold 100,000. The FTSE 100 rose 0.6%. Broker ratings on GSK remained mixed.
Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

7 February 2026
Aye Finance raised Rs 454.5 crore from 19 anchor investors ahead of its Feb 9 IPO, pricing shares at the top of a Rs 122–129 range. The company’s profit fell 40% to Rs 64.3 crore in the six months to September as bad loans rose to 4.85%. The IPO values Aye at about Rs 3,200 crore, below its last private round. Major investors include Nippon Life India and Goldman Sachs funds.
BAT share price closes near 52-week high as buyback rolls on ahead of results week

BAT share price closes near 52-week high as buyback rolls on ahead of results week

7 February 2026
British American Tobacco shares closed up 1.2% at 4,609 pence Friday, near a 52-week high. The company disclosed further share buybacks and management share purchases ahead of its Feb. 12 full-year results. BAT bought 121,668 shares for cancellation on Feb. 5. Investors await updates on nicotine alternatives and cash returns.
Anglo American share price slips as BofA turns neutral after copper outlook cut

Anglo American share price slips as BofA turns neutral after copper outlook cut

7 February 2026
Anglo American shares closed down 0.75% at 3,435 pence Friday after BofA Global Research downgraded the miner to “neutral” and raised its price target to 3,600 pence. Anglo cut its 2026 copper production guidance and warned of continued weakness at De Beers. The company expects $200 million in charges tied to its Chile copper operations in the second half of 2025.
Lowe’s stock closes lower as Wall Street slips; housing data and Fed minutes in focus
Previous Story

Lowe’s stock closes lower as Wall Street slips; housing data and Fed minutes in focus

Novo Nordisk halves Wegovy prices in parts of China as copycat competition looms
Next Story

Novo Nordisk halves Wegovy prices in parts of China as copycat competition looms

Go toTop